Stem cell therapies for recessive dystrophic epidermolysis bullosa

British Journal of Dermatology

Volumn 163, Issue 6, 2010, Pages 1149-1156

  Petrova, A ^a,b   Ilic, D ^b   McGrath, J A ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

blister; epidermis; inherited skin disease; regenerative medicine

Indexed keywords

ADIPOSE TISSUE; BONE MARROW; CELL POPULATION; CELL THERAPY; CLINICAL TRIAL; DISEASE SEVERITY; EPIDERMIS CELL; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE MUTATION; HAIR FOLLICLE; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PLACENTA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SKIN CELL; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD;

EPIDERMOLYSIS BULLOSA DYSTROPHICA; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 78649656327     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09981.x     Document Type: Review

References (103)

1. Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58: 931-50.
2. Chung HJ, Uitto J,. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatol Clin 2010; 28: 93-105.
3. Uitto J, McGrath JA, Rodeck U, et al. Progress in epidermolysis bullosa research: toward treatment and cure. J Invest Dermatol 2010; 130: 1778-84.
4. Stanley Jr. Rubinstein N, Klaus-Kovtun V,. Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol 1985; 85: 542-5.
5. Lavker RM, Sun TT,. Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations. Science 1982; 215: 1239-41.
6. Potten CS, Loeffler M,. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110: 1001-20.
7. Bickenbach Jr. . Identification and behavior of label-retaining cells in oral mucosa and skin. J Dent Res 1981; 60: 1611-20.
8. Potten CS,. Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int Rev Cytol 1987; 69: 271-319.
9. Barrandon Y, Green H,. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987; 84: 2302-6.
10. Jones PH, Watt FM,. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 1993; 73: 713-24.
11. Pellegrini G, Ranno R, Stracuzzi G, et al. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on Fibrin1. Transplantation 1999; 68: 868-79.
12. Li A, Simmons PJ, Kaur P,. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 1998; 95: 3902-7.
13. Alonso L, Fuchs E,. Stem cells of the skin epithelium. Proc Natl Acad Sci USA 2003; 100: 11830-5.
14. Blanpain C, Fuchs E,. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 2009; 10: 207-17.
15. Tani H, Morris RJ, Kaur P,. Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 2000; 97: 10960-5.
16. Radu E, Simionescu O, Regalia T, et al. Stem cells (p63(+)) in keratinocyte cultures from human adult skin. J Cell Mol Med 2002; 6: 593-8.
17. Chino T, Tamai K, Yamazaki T, et al. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 2008; 173: 803-14.
18. Pellegrini G, Dellambra E, Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001; 98: 3156-61.
19. Senoo M, Pinto F, Crum CP, et al. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007; 129: 523-36.
20. Sleeman MA, Watson JD, Murison JG,. Neonatal murine epidermal cells express a functional multidrug-resistant pump. J Invest Dermatol 2000; 115: 19-23.
21. Lyle S, Christofidou-Solomidou M, Liu Y, et al. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci 1998; 111: 3179-88.
22. Stasiak PC, Purkis PE, Leigh IM, Lane EB,. Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 1989; 92: 707-16.
23. Zhu AJ, Watt FM,. beta-Catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development 1999; 126: 2285-98.
24. Christiano AM,. Epithelial stem cells. Cell 2004; 118: 530-2.
25. Cotsarelis G,. Epithelial stem cells: a folliculocentric view. J Invest Dermatol 2006; 126: 1459-68.
26. Ito M, Liu Y, Yang Z, et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med 2005; 11: 1351-4.
27. Nowak JA, Polak L, Pasolli HA, et al. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 2008; 3: 33-43.
28. Morris RJ, Liu Y, Marles L, et al. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 2004; 22: 411-17.
29. Levy V, Lindon C, Harfe BD, et al. Distinct stem cell populations regenerate the follicle and interfollicular epidermis. Dev Cell 2005; 9: 855-61.
30. Steingrímsson E, Copeland NG, Jenkins NA,. Melanocyte stem cell maintenance and hair graying. Cell 2005; 121: 9-12.
31. Amoh Y, Li L, Katsuoka K, et al. Multipotent hair follicle stem cells promote repair of spinal cord injury and recovery of walking function. Cell Cycle 2008; 7: 1865-9.
32. Amoh Y, Yang M, Li L, et al. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res 2005; 65: 5352-7.
33. Amoh Y, Li L, Yang M, et al. Hair follicle-derived blood vessels vascularize tumors in skin and are inhibited by doxorubicin. Cancer Res 2005; 65: 2337-43.
34. Nijhof JGW, Braun KM, Giangreco A, et al. The cell-surface marker MTS24 identifies a novel population of follicular keratinocytes with characteristics of progenitor cells. Development 2006; 133: 3027-37.
35. Jensen UB, Yan X, Triel C, et al. A distinct population of clonogenic and multipotent murine follicular keratinocytes residing in the upper isthmus. J Cell Sci 2008; 121: 609-17.
36. Snippert HJ, Haegebarth A, Kasper M, et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 2010; 327: 1385-9.
37. Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, et al. Trans-gender induction of hair follicles. Nature 1999; 402: 33-4.
38. Gharzi A, Reynolds AJ, Jahoda CAB,. Plasticity of hair follicle dermal cells in wound healing and induction. Exp Dermatol 2003; 12: 126-36.
39. Paus R, Ito N, Takigawa M, et al. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003; 8: 188-94.
40. Jahoda CA, Reynolds AJ,. Hair follicle dermal sheath cells: unsung participants in wound healing. Lancet 2001; 358: 1445-8.
41. Biernaskie J, Paris M, Morozova O, et al. SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell 2009; 5: 610-23.
42. Toma JG, Akhavan M, Fernandes KJ, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3: 778-84.
43. Buranasinsup S, Sila-Asna M, Bunyaratvej N, et al. In vitro osteogenesis from human skin-derived precursor cells. Dev Growth Differ 2006; 48: 263-9.
44. Fernandes KJ, McKenzie IA, Mill P, et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004; 6: 1082-93.
45. Bartsch G, Yoo JJ, De Coppi P, et al. Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev 2005; 14: 337-48.
46. Chen FG, Zhang WJ, Bi D, et al. Clonal analysis of nestin vimentin+ multipotent fibroblasts isolated from human dermis. J Cell Sci 2007; 120: 2875-83.
47. Kuroda Y, Kitada M, Wakao S, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 2010; 107: 8639-43.
48. Sasaki M, Abe R, Fujita Y, et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008; 180: 2581-7.
49. Wu Y, Chen L, Scott PG, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25: 2648-59.
50. Mansilla E, Marin GH, Sturla F, et al. Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. Transplant Proc 2005; 37: 292-4.
51. Deng W, Han Q, Liao L, et al. Engrafted bone marrow-derived Flk-1+ mesenchymal stem cells regenerate skin tissue. Tissue Eng 2005; 11: 110-19.
52. Yoshikawa T, Mitsuno H, Nonaka I, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008; 121: 860-77.
53. Brzoska M, Geiger H, Gauer S, et al. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 2005; 330: 142-50.
54. Lee OK, Kuo TK, Chen WM, et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669-75.
55. Mitchell KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003; 21: 50-60.
56. Troyer DL, Weiss ML,. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008; 26: 591-9.
57. Moise KJ Jr. . Umbilical cord stem cells. Obstet Gynecol 2005; 106: 1393-407.
58. Strom S, Miki T,. Placental derived stem cells and uses thereof. US Patent Application Publication 2003; US2003/0235563A1.
59. Zhou Y, Genbacev O, Fisher SJ,. The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann N Y Acad Sci 2003; 995: 73-83.
60. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-77.
61. Ying QL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature 2002; 416: 545-8.
62. Masson S, Harrison DJ, Plevris JN, et al. Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells 2004; 22: 897-907.
63. Rabb H,. Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney. Am J Physiol Renal Physiol 2005; 289: F29-30.
64. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542-5.
65. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947-54.
66. Wagner JE, Laughlin M, Petz L,. Seventh Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, June 5-6, 2009. Biol Blood Marrow Transplant 2010; 16: 12-27.
67. Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009; 114: 4293-9.
68. Kamolz LP, Kolbus A, Wick N, et al. Cultured human epithelium: human umbilical cord blood stem cells differentiate into keratinocytes under in vitro conditions. Burns 2006; 32: 16-19.
69. Metallo CM, Azarin SM, Ji L, et al. Engineering tissue from human embryonic stem cells. J Cell Mol Med 2008; 12: 709-29.
70. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
71. Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000; 97: 11307-12.
72. Troy TC, Turksen K,. Commitment of embryonic stem cells to an epidermal cell fate and differentiation in vitro. Dev Dyn 2005; 232: 293-300.
73. Coraux C, Hilmi C, Rouleau M, et al. Reconstituted skin from murine embryonic stem cells. Curr Biol 2003; 13: 849-53.
74. Ji L, Allen-Hoffmann BL, Pablo JJ, et al. Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors. Tissue Eng 2006; 12: 665-79.
75. Metallo CM, Ji L, De Pablo JJ, et al. Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells. Stem Cells 2008; 26: 372-80.
76. Metallo CM, Ji L, Pablo JJ, et al. Directed differentiation of human embryonic stem cells to epidermal progenitors. Methods Mol Biol 2010; 585: 83-92.
77. Metallo CM, Azarin SM, Moses LE, et al. Human embryonic stem cell-derived keratinocytes exhibit an epidermal transcription program and undergo epithelial morphogenesis in engineered tissue constructs. Tissue Eng Part A 2010; 16: 213-23.
78. Aberdam E, Barak E, Rouleau M, et al. A pure population of ectodermal cells derived from human embryonic stem cells. Stem Cells 2008; 26: 440-4.
79. Margulis A, Zhang W, Garlick JA,. In vitro fabrication of engineered human skin. Methods Mol Biol 2005; 289: 61-70.
80. Hewitt KJ, Shamis Y, Carlson MW, et al. Three-dimensional epithelial tissues generated from human embryonic stem cells. Tissue Eng Part A 2009; 15: 3417-26.
81. Guenou H, Nissan X, Larcher F, et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 2009; 374: 1745-53.
82. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
83. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101-6.
84. Lowry WE, Richter L, Yachechko R, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 2008; 105: 2883-8.
85. Ebert AD, Yu J, Rose FF, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277-80.
86. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26: 1269-75.
87. Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26: 1276-84.
88. Soldner F, Hockemeyer D, Beard C,. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136: 964-77.
89. Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766-70.
90. Kaji K, Norrby K, Paca A, et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458: 771-5.
91. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4: 381-4.
92. Cho HJ, Lee CS, Kwon YW, et al. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 2010; 116: 386-95.
93. Tolar J, Ishida-Yamamoto A, Riddle M, et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 2009; 113: 1167-74.
94. Wagner JE, Ishida-Yamamoto A, McGrath JA, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010; 363: 629-39.
95. Conget P, Rodriguez F, Kramer S, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010; 12: 429-31.
96. Wong T, Gammon L, Liu L, et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008; 128: 2179-89.
97. Jonkman MF, Scheffer H, Stulp R, et al. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 1997; 88: 543-51.
98. Jonkman MF, Pasmooij AMG,. Revertant mosaicism-patchwork in the skin. N Engl J Med 2009; 360: 1680-2.
99. Almaani N, Nagy N, Liu L, et al. Revertant mosaicism in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2010; 130: 1937-40.
100. Pasmooij AM, Garcia M, Escamez MJ, et al. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2010; 130: 2407-11.
101. Gostynski A, Deviaene FC, Pasmooij AM, et al. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol 2009; 161: 444-7.
102. Park I-H, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-86.
103. Raya A, Rodriguez-Piza I, Navarro S, et al. A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc 2010; 5: 647-60.